Field cancerization in breast cancer.
Gadaleta E, Thorn GJ, Ross-Adams H, Jones LJ, Chelala C.
J Pathol. 2022 Jul;257(4):561-574. doi: 10.1002/path.5902. Epub 2022 May 3.
Tumor recurrence and in-field control after multimodality treatment of locally advanced esophageal cancer.
Thoen H, Ceelen W, Boterberg T, Van Daele E, Pattyn P.
Radiother Oncol. 2015 Apr;115(1):16-21. doi: 10.1016/j.radonc.2015.03.012. Epub 2015 Mar 25.
The role of tumor microenvironment and exosomes in dormancy and relapse.
Attaran S, Bissell MJ.
Semin Cancer Biol. 2022 Jan;78:35-44. doi: 10.1016/j.semcancer.2021.09.008. Epub 2021 Oct 30.
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Campagne O, Banerjee A, Gururangan S, Kilburn LB, Goldman S, Qaddoumi I, Baxter P, Vezina G, Bregman C, Patay Z, Jones JY, Stewart CF, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M.
Neuro Oncol. 2021 Oct 1;23(10):1777-1788. doi: 10.1093/neuonc/noab047.
Molecular determinants of tumor recurrence in the urinary bladder.
Cheng L, Zhang S, Davidson DD, MacLennan GT, Koch MO, Montironi R, Lopez-Beltran A.
Future Oncol. 2009 Aug;5(6):843-57. doi: 10.2217/fon.09.50.
Gastric carcinogenesis.
Gomceli I, Demiriz B, Tez M.
World J Gastroenterol. 2012 Oct 7;18(37):5164-70. doi: 10.3748/wjg.v18.i37.5164.
Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.
Kunath F, Spek A, Jensen K, Zengerling F, Schmidt S.
Syst Rev. 2015 Dec 18;4:182. doi: 10.1186/s13643-015-0167-3.
Disease recurrence after gut transplantation.
Osman M, Parekh N, Fujiki M, D'Amico G, Abu-Elmagd K.
Curr Opin Organ Transplant. 2021 Apr 1;26(2):207-219. doi: 10.1097/MOT.0000000000000856.
Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V, Mager AK, Goetz C, Detsch O, Theisgen HK, Friese M, Schwindt W, Gottschalk J, Kremer P.
Rofo. 2017 Jun;189(6):519-526. doi: 10.1055/s-0043-106189. Epub 2017 Jun 7.
Tumour microenvironment and pituitary tumour behaviour.
Marques P, Korbonits M.
J Endocrinol Invest. 2023 Jun;46(6):1047-1063. doi: 10.1007/s40618-023-02089-1. Epub 2023 Apr 15.
